Axomadol Explained

Axomadol (INN, USAN) (code name EN3324) is a synthetic, centrally-acting opioid analgesic related to tramadol which was under investigation by Endo Pharmaceuticals in collaboration with Grünenthal GmbH for the treatment of chronic, moderate to severe lower back pain and arthrosis.[1] [2] Development was halted after phase II clinical trials as it did not meet the pre-determined clinical endpoints.[3]

See also

Notes and References

  1. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain . Ford C . Endo Pharmaceuticals . 2011-06-30 . 2012-05-11.
  2. US . 20100331424 . Abandoned . Use of Axomadol for Treatment of Arthrosis Pain . 2010-12-30 . 2010-09-10 . Schiene K, Bloms-Funke P, Bothmer J, Lefeber C . Grünenthal GmbH.
  3. Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol . Ford C . Endo Pharmaceuticals . 2011-08-17 . 2012-05-11.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Axomadol".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.